REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr Pharma d.o.o. (Croatia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dr Pharma d.o.o. Profile Updated: July 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Dr Pharma d.o.o. is an enterprise in Croatia, with the main office in Odra, Zagreb. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Dr Pharma d.o.o. was incorporated on July 23, 2026. It currently has a total number of 13 (2025) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 15% in 2025. Over the same period, its total assets decreased by 3.53%. In, 2025, the company’s net profit margin increased by 11.35%.

Headquarters
Velika Cesta 33 Str.
Odra, Zagreb; Zagreb County; Postal Code: 10020

Contact Details: Purchase the Dr Pharma d.o.o. report to view the information.

Website: http://www.drpharma.hr

Basic Information
Total Employees:
Purchase the Dr Pharma d.o.o. report to view the information.
Financial Auditors:
Purchase the Dr Pharma d.o.o. report to view the information.
Incorporation Date:
July 23, 2026
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Poliklinika O3
Company Performance
Financial values in the chart are available after Dr Pharma d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-15%
Total Operating Revenue
-15%
Operating Profit
274.68%
EBITDA
198.86%
Net Profit/Loss for the Period
232.3%
Total Assets
-3.53%
Total Equity
89.24%
Operating Profit Margin
13.72%
Net Profit Margin
11.35%
Return on Equity (ROE)
29.15%
Debt / Equity
-2.08%
Quick Ratio
0.42%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?